Arana will contribute its proprietary proteins engineering technologies.

Both ongoing companies share in the expenses of advancement and commercialisation revenues. About Arana Therapeutics: Arana Therapeutics is an international biopharmaceutical company which uses superior technology to develop next generation medicines that will improve the lives of patients with inflammatory diseases and cancer. Arana Therapeutics’ innovative engineering technologies provide the basis for developing novel antibody items, for use in expanding biomedical marketplaces.Although there were significant declines in the incidence of some foodborne infections since surveillance began in 1996, these declines all occurred before 2004. The incidence of Salmonella attacks has remained between 14 and 16 cases per 100,000 individuals since the initial years of surveillance. ‘This year’s report confirms a very important concern, with two high-profile Salmonella outbreaks in the last year especially,’ stated Robert Tauxe, M.D., M.P.H, deputy director of CDC’s Division of Foodborne, Bacterial and Mycotic Diseases. ‘We recognize that people have reached a plateau in preventing foodborne disease and there must be new efforts to build up and evaluate food basic safety practices from the farm to the table.